Corient Private Wealth’s RxSight RXST Stock Holding History

Corient Private Wealth’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.58K	Sell	31,032 -40,633	-57%	-$337K	﹤0.01%	2805
2025 Q4	$747K	Buy	71,665 +41,503	+138%	+$416K	﹤0.01%	2058
2025 Q3	$271K	Buy	+30,162	New	+$265K	﹤0.01%	2187
2024 Q2	–	Sell	-4,071	Closed	-$210K	–	2379
2024 Q1	$210K	Sell	4,071 -5,900	-59%	-$290K	﹤0.01%	2079
2023 Q4	$402K	Hold	9,971	–	–	﹤0.01%	1725
2023 Q3	$278K	Hold	9,971	–	–	﹤0.01%	1781
2023 Q2	$287K	Buy	+9,971	New	+$222K	﹤0.01%	1721

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Corient Private Wealth's RXST Position: Q1 2026 in Review

Corient Private Wealth reduced its RxSight (RXST) stake by 57% in Q1 2026, selling an estimated $337K and leaving 31,032 shares worth $8.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

Corient Private Wealth first reported a position in RXST in Q2 2023 and has held it in 7 quarters since. The position peaked at $747K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Corient Private Wealth held 31,032 shares of RxSight worth $8.58K as of Q1 2026.
Corient Private Wealth sold 40,633 RxSight shares in Q1 2026, an estimated $337K.
RxSight made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2805 holding.
Corient Private Wealth first reported a position in RxSight in Q2 2023 and has held it in 7 quarters since.
Corient Private Wealth's RxSight position peaked at $747K in Q4 2025.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.